ClinicalTrials.Veeva

Menu

High Protein Effect on Body Composition and Sarcopenia Markers in Older Patients With Type 2 Diabetes Mellitus

N

National and Kapodistrian University of Athens

Status

Enrolling

Conditions

Type2 Diabetes Mellitus

Treatments

Other: 1.5 protein
Other: 0.8 protein

Study type

Interventional

Funder types

Other

Identifiers

NCT05457088
1288/03-07-2021

Details and patient eligibility

About

This study will investigate the impact of dietary protein intake on progressive muscle loss and functionality (sarcopenia) in older adults with type 2 diabetes mellitus. Sarcopenia is known to have a bidirectional interaction with type 2 diabetes mellitus. Therefore in order to address this bidirectional complication we suggest that an increased intake of dietary protein at 1.5 gr/kg/day (current official recommendation is 0.8 gr/kg/day) could help to treat the sarcopenia, which in turn will help to ameliorate the type 2 diabetes mellitus progression.

Enrollment

25 estimated patients

Sex

All

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • must have been diagnosed with type 2 diabetes mellitus during the last 5 years
  • must have BMI 18.5-24.9

Exclusion criteria

  • receive dietary supplements
  • extreme dietary habits
  • chronic inflammation disease
  • cancer
  • autoimmune disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

25 participants in 2 patient groups

intervention group
Experimental group
Description:
Dietary intervention with protein intake 1.5 gr/kg/day
Treatment:
Other: 1.5 protein
control group
Experimental group
Description:
Dietary intervention with protein intake 0.8 gr/kg/day
Treatment:
Other: 0.8 protein

Trial contacts and locations

1

Loading...

Central trial contact

Vassilis Paschalis, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems